Marta Domenech-Viñolas1, Leith León-Maldonado2,3,4, Paula Ramírez-Palacios5, Yvonne N Flores5,6,7, Víctor Granados-García8, Brandon Brown9, Edgar Corona5,10, Stephanie Liu5,11, Eduardo Lazcano-Ponce3, Jorge Salmerón3,4. 1. Hospital Universitario Bellvitge. Barcelona, España. 2. Cátedra Conacyt, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México. 3. Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México. 4. Centro de Investigación en Población, Políticas y Salud, Facultad de Medicina, Universidad Autónoma de México. Ciudad de México, México. 5. Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social. Cuernavaca, Morelos, México. 6. Department of Health Policy and Management, and Kaiser Permanente Center for Health Equity, University of California, Los Angeles. Los Angeles, CA, USA. 7. Cancer Prevention and Control Research Center, Fielding School of Public Health and Jonsson Comprehensive Cancer Center. Los Angeles, CA, USA. 8. Unidad de Investigación Epidemiológica y en Servicios de Salud Área Envejecimiento, Centro Médico Nacional Siglo XXI. Ciudad de México, México. 9. Department of Social Medicine, Population and Public Health, Riverside School of Medicine, University of California. Riverside, California, USA. 10. David Geffen School of Medicine, University of California. Los Angeles, CA, USA. 11. Department of Epidemiology, School of Public Health, University of Washington. Seattle, WA, USA.
Abstract
OBJECTIVE: To estimate the burden of genital warts (GW)in Mexico. MATERIALS AND METHODS: We estimated the annual incidence of GW based on data reported by specialist physicians. We also assessed GW treatment practices, the average cost of treatment, and the psychosocial burden of GW among patients. RESULTS: The annual incidence of GW in Mexico was estimated to be 547 200 cases. Treatment procedures vary by specialist and patient gender. The estimated annual cost was $195 million USD. The psychosocial impact of GW was slightly greater in males than females. CONCLUSIONS: This is the first evaluation of the burden of GW in Mexico. Our data suggest that GW are common, with significant health-related costs and psychosocial impact.
OBJECTIVE: To estimate the burden of genital warts (GW)in Mexico. MATERIALS AND METHODS: We estimated the annual incidence of GW based on data reported by specialist physicians. We also assessed GW treatment practices, the average cost of treatment, and the psychosocial burden of GW among patients. RESULTS: The annual incidence of GW in Mexico was estimated to be 547 200 cases. Treatment procedures vary by specialist and patient gender. The estimated annual cost was $195 million USD. The psychosocial impact of GW was slightly greater in males than females. CONCLUSIONS: This is the first evaluation of the burden of GW in Mexico. Our data suggest that GW are common, with significant health-related costs and psychosocial impact.
Entities:
Keywords:
Mexico; burden of disease; genital warts; healt care costs; psychosocial impact